7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          There are limited longitudinal data evaluating outcomes in idiopathic intracranial hypertension (IIH). We aimed to evaluate the long-term outcomes in a real-world cohort of patients with IIH and sought to establish the prognostic factors.

          Methods

          A longitudinal prospective cohort study was conducted over 9 years (2012–2021). Data included demographics and disease status. All consenting patients with IIH were recruited. Visual outcomes included visual acuity, Humphrey visual field and optical coherence tomography (OCT) imaging measurements. Headache frequency, severity, and impact were noted. We analysed the key variables impacting visual and headache outcomes.

          Results

          The cohort contained 490 patients with a confirmed IIH diagnosis. 98% were female with a mean body mass index (BMI) of 38 kg/m 2. Those with the highest OCT retinal nerve fibre layer had the worst visual outcomes. We noted a delayed decline, in the visual field and OCT ganglion cell layer after 12 months. In the medically managed cohort ( n = 426), we found that disease duration and change in BMI had the greatest influence on visual outcomes. There was a high burden of headache, with a daily headache at presentation and prior migraine history influencing long-term headache prognosis.

          Conclusions

          There is a delayed decline in visual outcomes in those with the most severe papilloedema. Disease duration and change in BMI were the key visual prognostic factors, therefore those with the more acute disease may require closer monitoring. Improving prognosis in IIH should focus on the potentially modifiable factor of weight management.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found
          Is Open Access

          Fitting Linear Mixed-Effects Models Using lme4

          Maximum likelihood or restricted maximum likelihood (REML) estimates of the parameters in linear mixed-effects models can be determined using the lmer function in the lme4 package for R. As for most model-fitting functions in R, the model is described in an lmer call by a formula, in this case including both fixed- and random-effects terms. The formula and data together determine a numerical representation of the model from which the profiled deviance or the profiled REML criterion can be evaluated as a function of some of the model parameters. The appropriate criterion is optimized, using one of the constrained optimization functions in R, to provide the parameter estimates. We describe the structure of the model, the steps in evaluating the profiled deviance or REML criterion, and the structure of classes or types that represents such a model. Sufficient detail is included to allow specialization of these structures by users who wish to write functions to fit specialized linear mixed models, such as models incorporating pedigrees or smoothing splines, that are not easily expressible in the formula language used by lmer. Journal of Statistical Software, 67 (1) ISSN:1548-7660
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The International Classification of Headache Disorders, 3rd edition (beta version).

            (2013)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A six-item short-form survey for measuring headache impact: the HIT-6.

              Migraine and other severe headaches can cause suffering and reduce functioning and productivity. Patients are the best source of information about such impact. To develop a new short form (HIT-6) for assessing the impact of headaches that has broad content coverage but is brief as well as reliable and valid enough to use in screening and monitoring patients in clinical research and practice. HIT-6 items were selected from an existing item pool of 54 items and from 35 items suggested by clinicians. Items were selected and modified based on content validity, item response theory (IRT) information functions, item internal consistency, distributions of scores, clinical validity, and linguistic analyses. The HIT-6 was evaluated in an Internet-based survey of headache sufferers (n = 1103) who were members of America Online (AOL). After 14 days, 540 participated in a follow-up survey. HIT-6 covers six content categories represented in widely used surveys of headache impact. Internal consistency, alternate forms, and test-retest reliability estimates of HIT-6 were 0.89, 0.90, and 0.80, respectively. Individual patient score confidence intervals (95%) of app. +/-5 were observed for 88% of all respondents. In tests of validity in discriminating across diagnostic and headache severity groups, relative validity (RV) coefficients of 0.82 and 1.00 were observed for HIT-6, in comparison with the Total Score. Patient-level classifications based in HIT-6 were accurate 88.7% of the time at the recommended cut-off score for a probability of migraine diagnosis. HIT-6 was responsive to self-reported changes in headache impact. The IRT model estimated for a 'pool' of items from widely used measures of headache impact was useful in constructing an efficient, reliable, and valid 'static' short form (HIT-6) for use in screening and monitoring patient outcomes.
                Bookmark

                Author and article information

                Contributors
                mark.thaller@nhs.net
                a.b.sinclair@bham.ac.uk
                Journal
                J Neurol
                J Neurol
                Journal of Neurology
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0340-5354
                1432-1459
                15 October 2022
                15 October 2022
                2023
                : 270
                : 2
                : 851-863
                Affiliations
                [1 ]GRID grid.6572.6, ISNI 0000 0004 1936 7486, Translational Brain Science, Institute of Metabolism and Systems Research, , University of Birmingham, ; Birmingham, B15 2TT UK
                [2 ]GRID grid.412563.7, ISNI 0000 0004 0376 6589, Department of Neurology, , University Hospitals Birmingham NHS Foundation Trust, ; Birmingham, B15 2TH UK
                [3 ]Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH UK
                [4 ]GRID grid.6572.6, ISNI 0000 0004 1936 7486, Cancer Research (UK) Clinical Trials Unit, , University of Birmingham, ; Birmingham, B15 2TT UK
                [5 ]GRID grid.9481.4, ISNI 0000 0004 0412 8669, Emergency Medicine, , Hull University Teaching Hospitals NHS Trust, ; Anlaby Rd, Hull, HU3 2JZ UK
                [6 ]GRID grid.412563.7, ISNI 0000 0004 0376 6589, Birmingham Neuro-Ophthalmology, , University Hospitals Birmingham NHS Foundation Trust, ; Birmingham, B15 2TH UK
                [7 ]GRID grid.1003.2, ISNI 0000 0000 9320 7537, Ophthalmology, School of Medicine, , University of Queensland, ; Queensland, 4006 Australia
                Author information
                http://orcid.org/0000-0001-7772-2157
                http://orcid.org/0000-0003-3639-7874
                http://orcid.org/0000-0001-8905-5734
                http://orcid.org/0000-0001-6285-0703
                http://orcid.org/0000-0003-0679-9696
                http://orcid.org/0000-0002-1406-5652
                http://orcid.org/0000-0002-6314-4437
                http://orcid.org/0000-0003-2777-5132
                Article
                11402
                10.1007/s00415-022-11402-6
                9886634
                36242625
                5b9a3ceb-cd18-4854-bf00-fd927d9a3629
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 24 June 2022
                : 22 September 2022
                : 23 September 2022
                Funding
                Funded by: Healthcare Quality Improvement Partnership
                Funded by: IIHUK registered patient charity (number 1143522)
                Funded by: Association of British Neurologists and Guarantors of the Brain for a 3-year Clinical Research Training Fellowship
                Funded by: FundRef http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Award ID: MR/KO15184/1
                Award Recipient :
                Funded by: National Institute of Health Research
                Award ID: NIHR-CS-011-028
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000282, Sir Jules Thorn Charitable Trust;
                Categories
                Original Communication
                Custom metadata
                © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2023

                Neurology
                pseudotumor cerebri,vision,headache,optical coherence tomography,outcome,prognosis,idiopathic intracranial hypertension

                Comments

                Comment on this article